Bloomberg -- GlaxoSmithKline Plc, the U.K.’s biggest drugmaker, plans to close a facility in Verona, Italy, affecting more than 500 research jobs, labor unions said. Glaxo’s northern Italian center, which specializes in neuroscience research, will be closed by the end of this year, the Filcem-Cgil, Femca-Cisl and Uilcem-Uil unions said in a joint e-mailed statement last night. Six facilities worldwide beside Verona will be closed by Glaxo, the unions said.
